| Breakdown | TTM | Mar 2025 | Mar 2023 | Sep 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.87M | 4.16M | 7.81M | 12.42M | 8.36M | 6.70M |
| Gross Profit | 791.00K | 1.29M | 3.52M | 5.20M | 3.34M | 2.70M |
| EBITDA | -3.70M | -4.13M | -2.37M | -325.00K | -1.31M | -2.22M |
| Net Income | -4.42M | -4.60M | -2.85M | -805.00K | -1.66M | -2.49M |
Balance Sheet | ||||||
| Total Assets | 8.14M | 8.46M | 11.60M | 12.45M | 12.76M | 14.66M |
| Cash, Cash Equivalents and Short-Term Investments | 2.11M | 374.00K | 4.12M | 2.81M | 5.44M | 7.27M |
| Total Debt | 418.00K | 544.00K | 643.00K | 725.00K | 653.00K | 325.00K |
| Total Liabilities | 2.14M | 2.90M | 2.84M | 3.63M | 3.31M | 3.35M |
| Stockholders Equity | 6.00M | 5.56M | 8.76M | 8.82M | 9.45M | 11.31M |
Cash Flow | ||||||
| Free Cash Flow | -3.41M | -4.90M | -1.45M | -2.63M | -2.31M | -1.06M |
| Operating Cash Flow | -2.84M | -4.36M | -826.00K | -2.51M | -1.58M | -571.00K |
| Investing Cash Flow | -571.00K | -450.00K | -532.00K | -112.00K | -735.00K | -408.00K |
| Financing Cash Flow | 3.71M | 1.05M | 2.65M | -50.00K | 491.00K | -136.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £28.51M | 12.60 | 8.48% | 2.09% | 21.43% | 44.70% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £9.84M | 13.62 | 4.23% | 3.20% | 10.26% | 45.18% | |
61 Neutral | £6.37M | -4.01 | -8.19% | ― | 63.81% | 71.62% | |
58 Neutral | £2.48B | 20.00 | -35.50% | 2.00% | -4.59% | -256.51% | |
44 Neutral | £1.85M | -6.65 | -21.12% | ― | -43.45% | -240.00% | |
42 Neutral | £4.13M | -0.42 | -76.54% | ― | -21.55% | 10.59% |